PATENT CLAIM ANALYSIS

Application Number: 15943903
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "468000"]

Abstract:
An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit comprises a pharmaceutically effective amount of a coated complex comprising clonidine bound to a cationic exchange resin, which is characterized by a twenty-four hour release profile with a single peak, wherein said oral clonidine dosage unit provides a therapeutically effective plasma concentration for at least about 70%, or at least 85% of the twenty-four hour period following the single dose administration. Both liquid and solid formulations are provided, as are methods of treating a patient by a single administration of a formulation of the invention so as to achieve a therapeutic effect for 24-hours.

Claim (Index 6):
A method for delivering an effective amount of clonidine for a twenty-four hour period which provides a single peak plasma concentration, the method comprising administering to a subject a single oral clonidine composition according to  claim 1  in the evening.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.73611
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12908796', '15200625', '13244706', '14016384', '15491547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6320842761569198
- 35 USC 102 Novelty (BERT): 0.524811554624371
- Combined Prediction Score: 0.6213570040036649
- Mean Citation Score: 240.450946
- Max Citation Score: 346.96793
- Similarity Product: 316.73617644609686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test